Philip C. Biggin
Papers
3
Total Citations
16
H-Index
3
About
Philip C. Biggin is a leading figure in computational and structural biology, with a primary focus on fragment-based drug discovery and the development of innovative methodologies to accelerate ligand progression. His major contributions center on overcoming the critical bottleneck in fragment-based approaches: transforming weakly binding initial hits into potent compounds. Biggin pioneered the **Binding-Site Purification of Actives (B-SPA)** technique, a powerful workflow that combines multi-step array synthesis with high-throughput (HT) crystallography. This method, detailed in his highly cited 2025 paper (9 citations), enables the efficient, large-scale progression of fragment hits by directly purifying active compounds within the binding site, bypassing traditional purification challenges. His 2023 work (4 citations) further demonstrated the use of low-cost robotics and crude reaction mixtures for rapid structural data collection, democratizing access to HT crystallography. Collectively, Biggin’s research has established a new paradigm for fragment hit-to-lead optimization, significantly reducing the time and cost of early-stage drug discovery. His work is instrumental for students and researchers seeking to bridge the gap between fragment screening and the development of potent, drug-like molecules, making him a pivotal figure in modern medicinal chemistry.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3